A post-doctoral position is available within the laboratory of Dr. Adrian Piliponsky at Seattle Children’s Research Institute, Department of Pediatrics, Pathology and Global Health, University of Washington (Seattle, WA).
Research in Dr. Piliponsky’s lab is focused on the regulation of inflammatory processes involving mast cells and myeloid cells, including allergy inflammation and inflammation during bacterial infections.
Publications of interest can be found at: Piliponsky AM et al. Immunol Rev 2018 (PMID 29431211), Piliponsky AM et al. Nat Immunol 2019 (PMID 30664762), Shubin NJ et al. Mucosal Immunol 2020 (PMID 32103153), Saha SS et al. J Allergy Clin Immunol 2021 (PMID 34324892).
The post-doctoral hired for the position will use an array of cellular and molecular approaches (ELISA, cell isolation, flow cytometry, histology, RNAseq and transcriptome analysis, qPCR, bacterial propagation; as well as animal models of bacterial infection and allergic airway and skin inflammation using mast cell and basophil specific conditional mice). They will also be expected to formulate, execute, and communicate research projects.
Requirements include a recent PhD and/or MD in Immunology or other cell biology- related fields (preferably including immunology training). PhDs graduated within two years are particularly encouraged to apply. Successful candidates should be highly motivated with an outstanding publication record (at least one first-author research paper published in peer-reviewed international journal) and work ethic. Candidates are required to have a strong research background in cellular immunology, biochemistry, and mouse models of disease, as well as excellent written and oral communication skills in English.
To apply: Please send: 1) cover letter briefly describing your research accomplishments, research interests and career goals, 2) your CV, and 3) a list of three references of your current and previous mentors, by email to adrian.piliponsky(at)seattlechildrens.org
Two postdoctoral positions are available jointly in the Department of Anesthesiology and Department of Pathology at Duke University Medical Center. Projects are funded for up to 4 years by recently approved grants from the NIH and the American Heart Association and will examine the role of mast cells at the vascular/tissue interface. Specifically, they will determine:
We apply a wide spectrum of techniques used in Molecular-, Cellular Biology, and Immunology, advanced in vivo approaches in mice and strains of genetically modified mice, and have access to biobanked clinical samples for confirmatory analysis. Both projects are highly multidisciplinary and involve close collaborations with researchers from Bioengineering, Infectious Diseases and Neuroradiology at Duke, and from the Department of Biochemistry and Biophysics at UNC (20min from Duke).
Interested candidates should provide cover letter, CV and contact information of 2 references. Please send applications to Dr. Jörn Karhausen, Department of Anesthesiology (jorn.karhausen(at)duke.edu) or Dr. Soman Abraham, Departments of Pathology, Immunology, and Molecular Genetics and Microbiology (soman.abraham(at)duke.edu).
Lab work includes immunological, molecular biology and microbiology methods, as well as in vivo mouse models of disease and work on human cells.
For more information please contact:
Professor Francesca Levi-Schaffer: francescal(at)ekmd.huji.ac.il
Head of Immunopharmacology lab, Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel